TransMedics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $108,761 | $114,305 | $96,850 | $81,174 |
Gross Profit | 60,845 | 69,161 | 59,862 | 47,924 |
EBITDA | 13,039 | 17,107 | 16,823 | 11,173 |
EBIT | 3,923 | 12,508 | 12,421 | 7,468 |
Net Income | 4,216 | 12,194 | 12,197 | 4,031 |
Net Change In Cash | 108,761 | 114,305 | 96,850 | 81,174 |
Free Cash Flow | -41,346 | 1,955 | -47,607 | -33,514 |
Cash | 330,094 | 362,751 | 350,217 | 394,812 |
Basic Shares | 35,683 | 35,288 | 34,678 | 34,179 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $241,623 | $93,459 | $30,262 | $25,639 |
Gross Profit | 154,093 | 65,272 | 21,159 | 16,635 |
EBITDA | -7,603 | -28,961 | -38,488 | -23,154 |
EBIT | -15,780 | -33,156 | -41,134 | -24,731 |
Net Income | -25,028 | -36,231 | -44,215 | -28,748 |
Net Change In Cash | 241,623 | 93,459 | 30,262 | 25,639 |
Cost of Revenue | 1,796 | |||
Free Cash Flow | -192,087 | -57,724 | -32,383 | -30,720 |
Cash | 394,812 | 201,182 | 25,580 | 24,581 |
Basic Shares | 32,517 | 29,556 | 27,616 | 24,702 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.12 |
2024-06-30 | $0.35 |
2024-03-31 | $0.35 |
2023-12-31 | $0.12 |
